VIVONA, Nicoletta
 Distribuzione geografica
Continente #
NA - Nord America 1.646
EU - Europa 810
AS - Asia 207
Totale 2.663
Nazione #
US - Stati Uniti d'America 1.643
FI - Finlandia 231
CN - Cina 167
IT - Italia 164
UA - Ucraina 140
IE - Irlanda 66
DE - Germania 50
GB - Regno Unito 32
FR - Francia 29
SE - Svezia 23
TR - Turchia 19
BE - Belgio 16
IN - India 15
RO - Romania 15
RU - Federazione Russa 15
PL - Polonia 13
NL - Olanda 6
KR - Corea 5
AT - Austria 3
BG - Bulgaria 3
CH - Svizzera 2
GR - Grecia 2
MX - Messico 2
CA - Canada 1
IR - Iran 1
Totale 2.663
Città #
Fairfield 186
Ashburn 165
Ann Arbor 127
Chandler 117
Houston 111
Woodbridge 109
Wilmington 90
Jacksonville 79
Cambridge 77
Seattle 74
Dublin 66
Medford 46
Palermo 42
Nanjing 40
Des Moines 38
New York 34
Princeton 27
Boardman 23
Tulsa 20
Izmir 19
Brussels 16
Changsha 16
Helsinki 14
Jinan 14
Beijing 13
Ningbo 13
Kraków 12
San Diego 11
Dearborn 10
Nanchang 10
Kumar 9
Altamura 8
Lawrence 8
Shenyang 8
Venice 8
Bremen 7
Hebei 6
Verona 6
Zhengzhou 6
Groningen 5
Milan 5
Pune 5
Seongnam 5
Durham 4
Düsseldorf 4
Haikou 4
Jiaxing 4
Kunming 4
Salerno 4
Taizhou 4
Tianjin 4
Catania 3
Guangzhou 3
Hangzhou 3
London 3
Ludwigshafen am Rhein 3
San Paolo di Civitate 3
Sofia 3
Taiyuan 3
Falls Church 2
Hefei 2
Matamoros 2
Moscow 2
Saint Petersburg 2
Wuhan 2
Adliswil 1
Atlanta 1
Auburn Hills 1
Baotou 1
Bergamo 1
Chicago 1
Cormeilles-en-Parisis 1
Edinburgh 1
Falkenstein 1
Frankfurt Am Main 1
Kiev 1
Kilburn 1
Lanzhou 1
Los Angeles 1
Mehlingen 1
Mountain View 1
Munich 1
New Bedfont 1
Norwalk 1
Ottawa 1
Paris 1
Quzhou 1
San Mateo 1
Southend 1
Stockholm 1
Tappahannock 1
Tehran 1
Washington 1
Zurich 1
Totale 1.802
Nome #
CEREBROTENDINOUS XANTHOMATOSIS: A SICILIAN FAMILY HARBOURING THE R362C MUTATION IN THE STEROL 27-HYDROXYLASE GENE 187
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma 154
Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple‑negative breast cancer SUM 159 cells 146
C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients. 142
Analysis of Possible Mechanisms Accounting for Raf-1 Kinase Inhibitor Protein Downregulation in Hepatocellular Carcinoma 141
Hypertension and diabetes mellitus are associated with cardiovascular events in the elderly without cardiovascular disease. Results of a 15-year follow-up in a Mediterranean population 134
PREVALENCE OF APOB VARIANTS IN A SAMPLE OF SUBJECTS WITH HYPOCHOLESTEROLEMIA 131
A NOVEL COMPOUND HETEROZYGOUS MUTATION OF THE LIPOPROTEIN LIPASE GENE IN A NEWBORN WITH CHYLOMICRONEMIA 128
CLINICAL AND MOLECULAR CHARACTERIZATION OF HYPERCHOLESTEROLEMIC SICILIAN FAMILIES AND DESCRIPTION OF 3 NOVEL MUTATIONS IN THE LDLR GENE 126
Mechanisms of Raf-1 Kinase Inhibitor Protein Dysregulation in Triple-Negative Breast Cancers and Identification of Possible Novel Therapeutic Approaches for These Tumors 123
SEVERE MALABSORPTION AND DECREASED TRIGLYCERIDE RICH LIPOPROTEINS PRODUCTION IN A PROBAND CARRYING A MUTATION ENCODING FOR A TRUNCATED APOLIPOPROTEIN B100 VARIANT (APO B 34.8). 111
Frequent alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein ratio in hepatocellular carcinoma 108
FAMILIAL LIGAND-DEFECTIVE APOLIPOPROTEIN B: IDENTIFICATION OF A FAMILY HARBOURING THE ARG3531CYS (FDB3531) OF THE APOB GENE 100
Two Italian kindreds carrying the Arg136-->Ser mutation of the Apo E gene: development of premature and severe atherosclerosis in the presence of epsilon 2 as second allele 95
ΒETA ARRESTIN-2: A NEW “ACTOR” IN THE LDL-R ENDOCYTOSIS? 92
PREVALENCE OF METABOLIC SYNDROME IN A RURAL SICILIAN POPULATION AND RELATIONS WITH CLINICAL EVENTS: THE VENTIMIGLIA HEART PROJECT. 92
INTERACTION OF THE INTRACELLULAR DOMAIN OF THE LOW DENSITY LIPOPROTEIN (LDL) RECPTOR WITH METALLOTHIONEIN2 (MT2). 81
Alteration of signaling pathways in hepatocellular carcinoma: identification of new pharmacological targets and possible prognosis markers. 81
VARIABLE PHENOTYPIC ESPRESSION IN A LIPID ABSORPTION DISORDER DUE TO A MOLECULAR DEFECT IN THE SARA2 GENE 79
COMPOUND HETEROZYGOUS FH AND FDB: IDENTIFICATION OF A SICILIAN FAMILY HARBOURING THE FDB3531 MUTATION AND THE Y398X MUTATION OF THE LDL RECEPTOR GENE. 78
A novel mutation in the Lipase Maturaction Factor 1 (LMF-1)gene responsible for severe hypertriglyceridemia 71
Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma: investigation of possible mechanisms 71
Possible mechanisms of Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma 58
Restoration of Raf-1 Kinase Inhibitor Protein levels as a possible therapeutic approach in hepatocellular carcinoma. 53
Analysis of UGT1A1*28 and DPYD*2A polymorphisms in Sicilians patients with metastatic colorectal cancer treated with Irinotecan and 5-fluorouracil. 52
Analysis of pharmacologic approaches able to restore RKIP function in hepatocellular carcinoma 50
NF-κB is a potential pharmacological target in triple negative breast cancers. 46
Totale 2.730
Categoria #
all - tutte 7.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.607


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019204 0 0 0 0 0 0 0 0 0 28 86 90
2019/2020745 100 43 52 83 81 75 82 31 73 33 59 33
2020/2021306 5 45 18 37 26 7 24 17 44 24 29 30
2021/2022254 11 61 6 0 4 10 10 8 35 34 11 64
2022/2023360 47 37 4 44 44 65 26 32 41 0 16 4
2023/2024181 11 26 23 18 13 57 15 13 5 0 0 0
Totale 2.730